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Abstract

Introduction

Despite extensive experimental work, neither the
effect of long term cryopreservation on vein graft archi tecture nor the failure of alloveins due to graft rejection
have yet been investigated. Herein, we investigated ul trastructurally: a) the integrity of rabbit jugular veins
following 1, 2 and 3 months of cryopreservation; b) the
outcome of the three-month cryopreserved vein auto- and
allografts after 1 month of implantation in the rabbit carotid artery ; and c) the immunologic response to cryopreserved vein allografts with and without seeded autologous endothelium. Prior to i mplantation , the cryopreserved rabbit veins were well-maintained except for endothelial cell damage. Following implantation , the cryopreserved vein autografts were comparable to fresh veins
with a complete endothelial lining. Conversely , only
one of the allograft was still patent with features of acute
rejection . After seeding with autologous endothelium ,
these explants failed shortly after surgery. We found
absence of endothelium and necrosis of the media components with neutrophil infiltration. Although three
months of cryopreservation does not affect vein graft architecture significantly, endothelial cells are damaged irrespective of the ti me of cryopreservation. Vein autografts promptly healed after one month of implantation
at which time a viable endothelial cell lining was restored from the host artery . Conversely, vein allografts,
with and without seeded autologous endothelium, failed
due to graft rejection . This study highlights that current
methods of cryopreservation do not reduce antigenicity
of venous allografts significantly.

As compared with earlier days (Kunlin, 1949) , the
i mprovements in cryo-techniques have resulted in significant tissue preservation following freezing and thawing
of human saphenous vein allografts (Ligush et al.,
1991). Preliminary clinical trials (Fujitani et al., 1992;
Harris et al. , 1993; Shah et al. , 1993 ; Walker et al.,
1993) have i ndicated the possibility of successfully using
the cryopreserved venous allografts for lower extremity
arterial reconstructions with the infected field and the
unavailability of fresh autologous tissue being the major
targets for their use. Consequently, tissue banking of
venous allografts is turning into a major task for people
involved in current surgical practice. Despite extensive
experimental work in this field (for a review see,
Faggioli et al., 1990; Greisler, 1991) , no result is yet
available on the possibility of cryopreserving vein grafts
efficiently for longer than 1 month .
On the other hand, animal studies (Street et al.,
1988; Showalter et al. , 1989) suggest that a short time
of cr yopreservation does not drastically affect the integrity of endothelial vein graft coverage. Functional results are contradictory. Findings suggesting a subtle endothelial cell and smooth muscle cell dysfunction, i.e.,
decreased prostacyclin synthesis (Showalter et al., 1989)
and lack of response to serotonin (Brockbank et al.,
1990), are at variance with those of a recent study which
documents biochemical and metabolic characteristics of
human venous allografts to be similar to those of fresh
veins (Ligush, et al. , 1991). Finally, the pathological
evaluation of explanted failed allografts have indicated
the importance of residual vein antigenicity and graft
atherosclerosis as additional problems (Greisler, 1991).
In the following experiment, we investigated morphologically: a) the effect of long term cryopreservation (up to
three months) on rabbit venous graft architecture and endothelial cell residual integrity; b) the outcome of venous auto- and allografts following 1 month of implantation into rabbit carotid arteries; c) the potential host
immunologic response to venous allograft implantation.
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Materials and Methods

the cells were washed three times with PBS and refed
with fresh ECCM. The medium was changed three
times a week. When 90 % confluent, the cultures were
trypsinized and rep lated at a 1: 6 ratio. Cells at the first
or second passage were used to seed the vein grafts.
RVECs identity was confirmed by the typical cobblestone appearance, with positive immunofluorescent staining for Factor VIII RA and negative actin staining.
Six animals were used as vein allograft donors.
Following excision, the jugular veins were de-endotheIialized with a collagenase dispase solution and cryopreserved for three months. At the time of the seeding experiment, the vein allografts were thawed, vigorously
and repeatedly rinsed with warm Medium 199 and
seeded with aprroximately 2 x 10 6 autologous endotheli al cells per cm surface area. Each vein was then placed
horizontally into a sterile tube with warm media, and in cubated at 37 ° C with continuous rotation (1 rpm). After
2 hours, the veins were removed from the sterile tube
and implanted into the carotid artery of the rabbit which
was previously used as source of endothelium. As a result, six rabbits in this group received a venous allograft
seeded with autologous endothelial cells. Explants were
performed between 4 days and 2 weeks.
Controls were included to verify that the autologous RVECs effectively adhered and spread onto the
venous allografts.

Vein harvest and cryopreservation
A total of 12 New Zealand white rabbits were
used to harvest fresh veins. The animals were anesthetized by intravenous sodium pentobarbital injection (30
mg/kg) and maintained under halothane and oxygen by
automatic ventilation. Jugular veins were excised with
no-touch dissection and gently flushed with warm (37°C)
Medium 199 (Gibco, Grand Island, NY, USA). Veins
were then ligated at both extremities, cannulated and
gently distended with freezing medium containing NCTC
135 (Gibco), 20% fetal bovine serum (FBS; Gibco),
17 .5 % dimethylsulfoxide (DMSO; Gibco) and 1 % nonessential aminoacids (NEAA; Gibco). Each of the distended veins was placed into a cryogenic vial and frozen
to -196°C at the controlled-rate of -5°C/sec. All steps
were performed under sterile conditions. The specimens
were then kept frozen at-196°C for 1, 2 and 3 months,
respectively.
At the end of the designated period, thawing was
accomplished by fast rewarming of the cryogenic vial to
37°C. After gentle flushing with Medium 199 , the veins
were processed for ultrastructural investigation.

Venous autograft and allograft implants
After 3 months of cryopreservation , both vein autografts (n = 3) and allografts (n = 3) were implanted
in a group of six animals. The vein grafts were sutured
with two end to side anastomoses in the rabbit carotid
artery using 9-0 nylon sutures under microscopical control. The carotid artery between the two anastomoses
was ligated at the end of procedure but not cut. Four
weeks after surgery, each animal was anesthetized, the
graft dissected free and the rabbit euthanatized. The
animal care followed the "Principles of Laboratory Animal Care" and the "Guide for the Care and Use of Laboratory Animals" (NIH Publication No 80-23 , revised
1985).
Controls were performed by implanting non-cryopreserved autologous veins for four weeks.

Transmission and scanning electron microscopy
Representative samples from each experimental
step were processed for transmission electron microscopy (TEM) and scanning electron microscopy (SEM).
Each of the explanted venous grafts was cannulated, perfused under physiologic pressure (100 mm Hg) with
warmed (37°C) Krebs-Henzleit saline solution (Sigma,
St. Louis, MO, USA) and fixed with cacodylate-buffered
glutaraldehyde in-situ. Subsequently , the specimens
were fixed with glutaraldehyde for 2 hours, opened
along their ventral surface, and cut into serial strips.
After 1 hour of 1 % osmium tetroxide post-fixation, the
samples were repeatedly washed in distilled water and
dehydrated in a series of graded alcohols. Samples for
TEM were embedded in epoxy resin. Thin sections were
counterstained with uranyl acetate and lead citrate and
observed in a Philips 400T transmission electron microscope. Samples for SEM were critical point dried, sputter-coated with 10 nm of gold and viewed in a Philips
505 scanning electron microscope.

Seeding with autologous endothelium
Twelve animals were used to perform the following experiment. To enzymatically harvest rabbit vein
endothelial cells (RVECs), freshly excised jugular veins
(n = 6) were incubated twice (20 minutes each step)
with a 0.2 % collagenase dispase (Boheringer Mannheim
Co., Indianapolis, IN, USA) solution. Following incubation, the solution containing the RVECs was centrifuged at 300 g for 10 minutes at 4 °C, the supernatant
discharged and the pellet suspended in 4 ml of endothelial cell complete medium (ECCM) [Medium 199 containing 20% FBS, 100 IU/ml heparin (Organon, Inc.), 10
µg/ml endothelial cell derived growth factor (Boheringer
Mannheim Co.), 1 % vitamins (Gibco), 1 % NEAA, 1 %
sodium pyruvate (Gibco), 0.1 % PSN (penicillin, streptomycin, neomycin; Gibco) , and 0.05 % gentamicin
(Gibco)]. The RVECs were then plated into T25 flask
and incubated at 37°C with 5 % C0 2 . After 24 hours,

Results
Ultrastructure of cryopreserved vein grafts
Following 1, 2 and 3 months of cryopreservation,
no significant ultrastructural difference was found among
rabbit vein grafts.
By SEM, the vein graft surface was corrugated
and partially covered by endothelial cells (Fig. 1). Foci
of endothelial cell shedding associated with surface blebbing and loss of intercellular contacts were seen.
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adventitia contained a marked perivascular infiltrate of
lymphocytes, plasma cells, monocyte/macrophages and
neutrophils.

By TEM, most of the endothelial cells showed
pyknotic nuclei and cytoplasmic vacuoles (Fig. 2). The
basal lamina was present. The elastic lamina showed a
slight dissociation of elastotubules from the elastic
moieties. Smooth muscle cells were generally unremarkable except for variable lysis of myofilaments and
cytoplasmic vacuolization (Fig. 3).

Ultrastructure of seeded vein allograft explants
Prior to implantation, controls showed a discontinuous crowding of rounded endothelial cells on the surface of the vein allograft (Fig. 11). Some endothelial
cells spread over the graft surface (Fig. 12); filopodial
contacts were observed .
After implantation, five of the six vein grafts
thrombosed within a short time (four days to two
weeks). In three cases , the thrombus was organized
within a fibrotic vein. Technical defects were ruled out.
One vein graft was patent with no gross evidence of
thrombus formation (patency rate 12.6%).
By SEM , the patent allograft was de-endothelialized. The surface showed a fibrin-mesh with acti vated platelets and erythrocytes (Fig. 13). Microthrombi were also present.
By TEM, no endothelial celis could be recog nized. The inner elastic lamina was interrupted and had
a sieve-like appearance (Fig. 14). There was necrosis of
the media with residual smooth muscle cells having
pyknotic nuclei and degenerated cytoplasms (Fig. 15).
Cell debris and neutrophilic infiltration were common
findings (Fig. 16). Neutrophils were also observed fixed
in a state of granule exocytosis.
On the contrary, TEM of the thrombosed allografts showed a fibrotic media containing fibroblasts and
scant inflammatory cells. Smooth muscle cells were
virtually absent.

Ultrastructure of autologous venous explants
After 1 month of implantation, the 3-month cryopreserved vein autografts as well as the non cryopreserved autografts (control) were patent and showed identical ultrastructural findings .
By SEM, the cryopreserved autografts were continuously lined with flat endothelium (Fig. 4). The endothelial cells were orderly aligned along the direction
of the blood flow. Neither platelets nor fibrin were ob served. Leukocyte adherence was unremarkable.
TEM of endothelium showed nuclei with finely
dispersed chromatin and an occasional nucleolus (Fig .
5). The cytoplasm contained cisternae of rough endoplasmic reticulum, mitochondria and abundant intermediate filaments. Stress fibers were found in endothelial
cells lining the perianastomotic regions of the graft.
Tight junctions were present. Scant leukocytes were observed in the subendothelial space. The elastic lamina
was continuous . In the media, the elastic fibers in creased throughout and focally condensed into small
laminae. Many of the smooth muscle cells had dilated
cisternae of rough endoplasmic reticulum containing
moderately-dense synthesized material (Fig. 6).

Ultrastructure of vein allograft explants
After 1 month of implantation , only one of the 3
months cryopreserved vein allografts was still patent
(patency rate 12.6%). The other explants were throm bosed and transformed into fibrotic conduits.
SEM of the patent allograft showed an endothelialized graft surface with marked leukocyte adherence
(Fig. 7). The surface inflammatory infiltrate, starting a
few mm from the anastomotic sites, was homogeneously
distributed along the length of the graft. Many leukocytes were observed while migrating through evident interendothelial gaps, into the subendothelial space. Retraction of the endothelium was noticed especially in the
mid-portion of the graft (Fig. 8).
By TEM, endothelial cells had convoluted nuclei
with finely dispersed chromatin and abundant cytoplasm.
Apart from the usual assortment of organelles, the cytoplasm contained a number of ribosomes, polyribosomes,
and small profiles of rough endoplasmic reticulum.
Weibel-Palade bodies were also found. The subendothelial space was occupied by small and large, 'blast-like' ,
lymphocytes, monocyte/ macrophages as well as migrated smooth muscle cells (Fig . 9). These latter cells
had a few peripheral contractile filaments and numerous
cisternae of rough endoplasmic reticulum. The elastic
laminae were fragmented; in the media, lymphocytes
were associated with smooth muscle cells having a synthetic appearance, as well as fibroblasts (Fig. 10). The

Discussion
In this study, we first evaluated the ultrastructure
of the rabbit vein tissue after 1, 2 and 3 months of cryopreservation, respectively. Basically, no significant difference was found within the investigated specimens.
Consequently , an adverse effect of storage time (up to 3
months) and procedures (storage under liquid nitrogen at
-196 ° C) on vein graft architecture was ruled out. This
means that tissue banking of cryopreserved vein grafts
is feasible within a reasonably short period of time.
All the specimens showed marked endothelial cell damage including, cell shedding, nuclear pyknosis, and cytoplasmic vacuolization, along with good preservation of
the medial components, i.e., smooth muscle cells and
elastic tissue. Unexpectedly, the use of improved techniques for tissue cryopreservation, such as, delicate
procedures of tissue handling, vein irrigation with warm
(37°C) solutions, the use of DMSO as a cryoprotectant
(Barner et al., 1966; Boren et al., 1977; L'Italien et al.,
1979; Sitzmann et al., 1984), rapid freezing (-5°C/sec),
and fast thawing, did not prevent damage to the venous
endothelial surface at all. This finding is at variance
with previous studies (Dent et al., 1974; Weber et al.,
1976; Ladin et al., 1982; Lindanauer et al., 1982; Street
et al., 1988; Brockbank et al., 1990) which found morphologically intact endothelium after vein storage at low
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Figure 1. Three month cryopreserved vein graft showing the endothelial cell lining. SEM. Bar = 10 µm.
Figure 2. Three month cryopreserved vein graft. The endothelial cells show surface blebbing (large arrowhead) and
pyknotic nuclei. A slight dissociation of the elastotubules is also observed (small arrowheads). TEM . Bar = 1 µm .
Figure 3. Three month cryopreserved vein graft. Smooth muscle cells are unremarkable. TEM . Bar = 1 µm.
Figure 4. Cryopreserved autologous vein graft. Following one month of implantation , the graft surface is completely
lined with a flat endothelium. SEM. Bar = 10 µm .
Figure 5. Cryopreserved autologous vein graft. One month of implantation. By TEM , the endothelial cells show oval
nuclei with finely dispersed chromatin . The cytoplasm contains a few profiles of rough endoplasmic reticulum , mitochondria and intermediate filaments . TEM. Bar = 1 µm .
Figure 6. Cryopreserved autologous vein graft. One month of implantation. The smooth muscle cells show abundant
rough endoplasmic reticulum; some cisternae are dilated and contain moderately-dense synthesized material
(arrowheads). TEM. Bar = 10 µm.
Figure 7. Cryopreserved allovein graft. Following one month of implantation , SEM shows a continuous endothelium
with a marked leukocyte adherence. SEM. Bar = 10 µm.
Figure 8. Cryopreserved allovein graft. One month of implantation. Retraction of endothelial cells (arrowheads) as
observed in the mid-portion of the graft. SEM . Bar = 10 µm .
Figure 9. Cryopreserved allovein graft. One month of implantation. TEM of the subendothelial space shows
lymphocytes (ly) , monocytes (mo), and modified smooth muscle cells (arrows). TEM . Bar = 5 µm.
Figure 10. Cryopreserved allovein graft. One month of implantation . Lymphocytes (ly), plasma cells (pc), and
smooth muscle cells with a synthetic appearance are observed in the media. TEM. Bar = 1 µm.
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Additionally, the presence of residual endothelium
on vein allografts can be deleterious rather than beneficial since injured endothelium can drastically trigger immunological reactions leading to graft failure. Further,
they can determine production of procoagulant factors,
such as thromboplastin and factor V, although this issue
has not been yet investigated in cryopreserved veins.
Additionally, Elmore et al. (1991) showed that the endothelium of cryopreserved veins has more vasoconstric~ive properties than the fresh endothelium. Accordingly,
rn the present study, all but one of the cryopreserved
vein allografts were thrombosed and fibrosed after one
month of implantation.
Furthermore, the ultrastructure of the still patent
allograft showed features of acute graft rejection. These
latter allografts included a remarkable mixed inflammatory infiltrate mainly affecting the intima and adventitia.
In addition to lymphocytes, which are probably responsible for initiating immune-mediated graft damage, varying numbers of monocytes, plasma cells and neutrophils
were also seen. 'Activated' lymphoid cells with 'blastlike' features were also present. Interestingly, the endothelial lining, presumed to be autologous in nature, was
spared; whereas, the media featured foci of inflammatory cells, modified smooth muscle cells, fibroblasts, and
degenerated elastic tissue.
These findings further extend the issue of venous
allograft antigenicity. Although most of previous studies
have concentrated upon endothelial cell antigenicity,
smooth muscle cells and extracellular matrix components, such as the elastic tissue, can play an additional
role in the mechanism of vein graft rejection. Support
of this hypothesis is the finding of smooth muscle cell
expression of molecules (class I and II major histocompatibility complex antigens as well as vascular cell adhesion molecule-I, VCAM-1) which are known to be important in directing immune-mediated responses (Munro
and Cotran, 1988; Briscoe et al., 1992). On the other
hand, elastic tissue can be potentially immunogenic since
elastin-derived peptides were found implicated in the
pathogenesis of human inflammatory abdominal aneurysms (Gargiulo et al., 1993).
Further evidence of this issue comes from the observation of explants of vein allografts seeded with autologous endothelium. All but one of these grafts thrombosed within a very short time (from four days to two
weeks). This early failure was believed to be a consequence of incomplete endothelial cell seeding. Ultrastructural examination of the seeded vein grafts before
implantation showed many areas lacking any cell coverage with highly thrombogenic subendothelial matrix
components exposed to the blood flow. Of interest,
TEM of a four day patent explant showed neutrophilic
infiltration and necrosis of the media. The presence of
neutrophils, which are considered highly specific for the
diagnosis of rejection in other tissues, is particularly
important since they are suspected to augment immunological damage to target structures by delivering lytic
enzymes as well as metabolic products, e.g., hydrogen

Figure 11. Allovein graft seeded with autologous endothelium. Prior to implantation, TEM shows rounded endothelial cells on the graft surface. TEM. Bar = 5 µm.
Figure 12. Allovein graft seeded with autologous endothelium. SEM shows some spread endothelial cells with
numerous filopodial projections. Note that subendothelial matrix is exposed at different sites (arrowheads).
SEM . Bar = 2 µm.
Figure 13. Allovein graft seeded with autologous endothelium. Following four days of implantation, the graft
surface is covered with fibrin, dendritic (arrowheads)
and fully spread (arrows) platelets, as well as erythrocytes . SEM. Bar = 5 µm.
Figure 14. Allovein graft seeded with autologous endothelium. The four day explant shows frayed elastic lamellae with a sieve-like appearance. Elastotubules (arrowheads) and lipid droplets are also evident. TEM.
Bar = 0.5 µm.
Figure 15. Allovein graft seeded with autologous endothelit:m. After four days of implantation, TEM shows
necrosis of smooth muscle cells (arrowheads). TEM.
Bar = 1 µm.
Figure 16. Allovein graft seeded with autologous endotheli m. Four days after implantation. A neutrophil is
observed in correspondence with cell debris and remnants of elastic tissue (arrowheads). TEM. Bar = 1
µm.

temperatures in the presence of a cryoprotectant agent
(ammonium acetate, glycerol, and DMSO). In accordance with our results, disruption of the endothelial layer
was ultrastructurally demonstrated in human specimens
by Ligush et al. (1991). We further documented this issue indirectly by evidencing a failure in culturing endothelic.l cells from analogous rabbit cryopreserved specimens before implantation (Faggioli et al., 1993). Thus,
our iew is that current methods of cryostabilization do
not maintain endothelial cell integrity effectively.
However, from our results, the significance of
preserving an intact endothelium remains questionable
for a least two reasons. First, four weeks after implantation, all the cryopreserved vein autografts behaved like
fresh autografts. They were patent and completely endothelialized with early features of media arterialization.
Since endothelium injured by cryopreservation is extremely susceptible to sloughing when exposed to the arterial flow (Elmore et al., 1991; Faggioli et al., 1993),
it car. be supposed that a reendothelialization takes place
in cryopreserved rabbit vein autografts, the source of the
neo-endothelium being the host arterial tissue. Second,
unlike previous statements (Schwartz et al., 1967; Tice
and Zerbino, 1972; Dent et al., 1974; Axthelm et al.,
1979; L'Italien et al., 1979; Malone et al., 1980; Theide
et al., 1981; Ladin et al., 1982; Showalter et al., 1989;
Broc:( bank et al., 1990; Fujitani et al., 1992), we feel
that ~ryopreservation does not significantly reduce the
antigenicity of venous allografts.
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peroxide, into the matrix (Adams et al., 1990). Neutrophilic recruitment followed by disruption of media components can therefore be responsible for the fibrotic
evolution of the older failed explants.
The present results, which are at variance with
most of the previous work on this subject, need obvious
confirmation in other experimental settings, including
the ongoing clinical trials as well. However, cryo-technologies for preserving vein tissue and, most importantly, the immunological characteristics of the cryopreserved vein allografts with and without endothelial cells
should be more extensively investigated. In our opinion,
future issues to be explored in order to resolve the immunological problems would be:
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shown).
b) Human leukocyte antigen (HLA) matching instead of the actually recommended ABO matching whose
clinical efficacy is questionable in light of the results
obtained in the clinical settings (Harris et al., I993;
Shah et al., I993; Walker et al., I993).
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integrins, such as, the intracellular adhesion molecule-I
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those of fresh allografts, which are notoriously poor.
Some recent studies showed that acceptable patencies are
achieved in cryopreserved venous allografts only with
concomitant immunosuppressive and an ti platelet therapy
[Augelli et al., 1991; Miller VM, Bergman RT,
Gloviczki P, Brockbank KGM. (1993). Cryopreserved
venous allografts: effects of immunosuppression and
antiplatelet therapy on patency and function. J Vase Surg
18: 216-226]. In this respect our study further supports
these data.

K.A. Robinson: Please comment further on the rationale for autologous endothelial cell (EC) seeding of the
cryopreserved allografts. Presumably one reason is to
enhance compatibility in the host ; yet your results indicate no difference between seeded versus unseeded cryopreserved allografts in terms of immunologic/inflammatory sequelae.
Authors: The rationale for autologous EC seeding was
exactly to reduce immunoreaction by increasing compatibility . Previous studies showed that endothelium is the
major immunological target in graft rejection (Greisler,
1991). Our results do not support this view. Smooth
muscle cells and other components of the venous wall
seem to be responsible for immunoreaction, despite the
fact that some authors reported better patencies in de-en dothelialized venous allografts if compared with intact
alloveins [Galumbeck MA, Sanfilippo FP , Hagen PO,
Seaber AV, Urbaniak JR. (1987). Inhibition of vessel
allograft rejection by endothelial removal. Ann Surg
206: 757-764].
K.A. Robinson: How does the ultrastructure (particularly of the EC) of the cryopreserved specimens compare
to freshly harvested veins?
Authors: Basically, we found that cryopreservation
significantly affected the endothelial cell viability.
Ultrastructurally, a variable, but constant, EC loss was
appreciated in the examined samples. Residual endothelium showed nuclear changes, including chromatin
clumps and pyknosis, as well as features of cytoplasmic
damage, such as mitochondrial swelling and vacuolization. Surface blebbing was also prominent. The EC
suboptimal morphological preservation is also in agreement with the failure in culturing EC from analogous
cryopreserved specimens (Faggioli et al., 1993). However, it should be also mentioned that smooth muscle
cells and matrix components, which showed an almost
unremarkable ultrastructural morphology, were less affected by the freezing-thawing cycle.

Discussion with Reviewers
K.A. Robinson: Perhaps the most interesting finding is
the disparity between your results and those of previous
investigators with regard to both long-term patency and
immunologic rejection of cryopreserved homografts.
Are methodologic differences to blame?
Authors: Early studies on this subject showed better
patencies in cryopreserved allografts when compared to
fresh controls. However, cryopreservation techniques in
these ·studies were somehow "rudimental" and significant
cell damage probably occurred during the freezing-thawing cycle. We believe that the cell loss may have decreased the overall antigenicity of the venous wall. In
more recent studies , improved freezing techniques allowed a better preservation of all the wall components;
therefore, the patencies obtained were comparable to

M.F. Sigot-Luizard: You said, and I think probably
rightly, that "from our results, the significance of preserving an intact endothelium remains questionable".
Moreover, you supposed that the reendothelialization of
the autograft vein is provided by the host arterial tissue.
Did you perform some experiments to be able to confirm
this hypothesis?
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specimen in the cooling device. Are the actual freezing
and thawing rate curves known (for example, measured
by thermocouples inserted in the specimen)? Is ice
crystal damage or formation of intracellular ice seen
with this cryoprotectant and with these rates of cooling?
Could extensive damage produced by the freezing and
thawing technique effectively mask any minor damage
related to the length of storage?
Authors: Thermoelectric couples were not used in our
model. Although previous studies stated that DMSO, at
the concentration herein employed, efficaciously prevent
the formation of ice crystals intracellularly , we believe
that no conclusive data exist on this issue. Strictly
speaking, cryoprotection with DMSO means the addition
of solutes and the reduction of intracellular free water to
living cells in order to increase survival rates after
freezing and thawing. Many living cells, subjected to
slow freezing rates when suitably cryoprotected survive
freezing and thawing as a result of the slow removal of
water from cells and the growth of extracellular ice.
However, survival of a living cell following the freezing-thawing cycle does not mean suitable preservation of
the original fine structure of that cell. Thus, we believe
that ice crystals do occur intracellularly. However,
turning to the preservation of vein components and in
particular of EC , we do not know how much EC damage
is proportionally caused by freezing-thawing per se, or
by DMSO cryoprotection, which is also potentially deleterious. In this respect, the resulting cell damage can
obviously mask any additional, even though minimal,
damage caused by storage conditions.

Authors: Yes, we did (Faggioli et al., 1993). First, we
studied two-hour explants of cryopreserved rabbit vein
autografts and found that, at this time, the EC were
completely lost from the venous surface, the surface being lined with a mesh of fibrin and fully spread platelets
only. Second, we found that analogous one month explants showed a completely endothelialized graft surface.
Consequently, we supposed that reendothelialization was
mostly provided by the host arterial tissue.
R.M. Albrecht: The findings regarding t e antigenicity
of remaining EC and of the other vessel components are
of considerable importance. While the non-seeded grafts
were first observed at one month , the seeded grafts were
observed as early as 4 days. Most of these apparently
showed evidence of acute rejection. Was this simply a
general inflammatory response to the damaged tissue or
have the animals somehow been previously sensitized to
the foreign antigen so that this very rapid response occurs? Is there any data which indicates the unseeded
alloveins also shows this rejection response by the 4 day
time point?
Authors: We suspect that the pathologic picture we observed in the seeded vein allografts may correspond to
an early stage of the otherwise typical features of acute
rejection found in the unseeded alloveins. This finding
is not surprising because rabbit jugular veins from different inbred strains were employed as vein allografts.
Under these circumstances, an acute graft rejection is
reasonably expected within a few days or weeks depending on the number and immunogenic strength of the antigens present in the graft but absent in the recipient.
Alternatively, one can speculate that an unexpected form
of hyperacute graft rejection may have occurred in these
specimens. As you suggest, an hyperacute rejection is
generally associated with the presence of preformed circulating antibodies in the recipient directed against
donor HLA or ABO antigens. However, this does not
seem to be so in the present case. Further, it should be
also mentioned that, at least in humans, not all patients
with circulating antidonor HLA or ABO antigens develop
hyperacute rejection; there are also occasional cases that
demonstrate no detectable antidonor antobodies in recipient serum or allograft eluates, even if clinically and
pathologically characterized as hyperacute rejection
[Sanfilippo FP. (1990). Renal Transplantation. In: The
Pathology of Organ Transplantation. Sale GE (ed .). Butterworths. pp. 51-101). Regarding to your last question,
at the present, we have no data on the unseeded alloveins.

R.M. Albrecht: Were any studies performed in vitro or
in vivo to see if the seeded autologous EC remained in
place during pulsatile flow at arterial pressures?
Authors: We examined a couple of two-hour explants
and we did not find any endothelial cell on the graft surface . However, as discussed in the paper, at that time
we did not succeed in achieving a continuous and flat EC
monolayer on the graft surface. Subsequently, we examined the 22-hour seeded alloveins and found that approximately 75 % of the original EC were still present after
2 hours of implantation.
R.M. Albrecht: Why is bovine serum, rather than autologous rabbit serum, used in the freezing media; might
this not actually increase the antigenicity of the vessels
if bovine molecular species bind in the subendothelium?
Authors: This comment is very appropriate and we
thank the reviewer for focusing o'n this subject. We
chose bovine serum rather than rabbit serum because this
is the technique used in most clinical studies and we
elected to keep all variables as close as possible to the
clinical settings . Moreover, our serum is heat-inactivated and should not interfere significantly, even if still
present on the venous surface after careful washing, with
immunological reactions.

R.M. Albrecht: The actual rates of freezing and thawing of the cells and tissues often vary over time, i.e., are
not linear, due to the latent heat of fusion, conductivity,
exposed surface area, etc. Thus, even if the cooling device tools a block of metal at a certain rate it is still important to know the actual cooling curve of a biological
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